Free Trial Data Usage Terms
Effective Date: April 16, 2026
Applies to: All Services during Free Trial periods
Document ID: QUOME-LEGAL-FREETRIAL-001
1. Scope
These Free Trial Data Usage Terms ("Trial Terms") apply to all Users accessing Quome Services during a free trial period, as described in Section 8.4 of the Terms of Service. These Trial Terms supplement and form part of the Terms of Service.
2. R&D Data Usage Rights During Free Trials
2.1 Grant of R&D License
During any free trial period, in addition to the license granted under Section 4.2 of the Terms of Service, you grant Quome, Inc. a non-exclusive, royalty-free, worldwide license to use, analyze, and process your User Content and Usage Data for research and development purposes ("R&D Purposes"), including:
(a) Service improvement — analyzing usage patterns, resource configurations, deployment behaviors, and workflow designs to improve the Quome platform;
(b) Feature development — identifying common use cases, integration patterns, and user needs to inform new feature development;
(c) Performance optimization — benchmarking infrastructure configurations, query patterns, and application architectures to optimize platform performance;
(d) Aggregate analytics — generating de-identified, aggregated insights about platform usage, infrastructure trends, and technology adoption; and
(e) Training and documentation — creating anonymized examples, templates, and best-practice guides derived from common deployment patterns.
2.2 Limitations on R&D Usage
The R&D license granted in Section 2.1:
(a) Does not include the right to disclose, publish, or share your identifiable User Content with any third party;
(b) Does not include the right to use your User Content for advertising or marketing to third parties;
(c) Does not include the right to train third-party AI models on your identifiable User Content;
(d) Requires de-identification — any User Content used for R&D Purposes outside of direct service improvement will be de-identified or aggregated such that it cannot reasonably be used to identify you, your Organization, or any individual; and
(e) Excludes PHI — if you have executed a Business Associate Addendum, no Protected Health Information (PHI) will be used for R&D Purposes under any circumstances, regardless of trial status.
2.3 What We May Analyze
During free trials, Quome may analyze the following categories of data for R&D Purposes:
| Category | Examples | R&D Use |
|---|---|---|
| Deployment configurations | App specs, resource tiers, sidecar configs | Identify common patterns, optimize defaults |
| Database schemas | Table structures, index patterns, query shapes | Improve managed database recommendations |
| Workflow designs | Step graphs, trigger configs, execution patterns | Enhance workflow engine and templates |
| Storage patterns | Bucket configurations, access patterns, file types | Optimize storage provisioning |
| Agent configurations | Model selections, tool bindings, prompt patterns | Improve agent framework |
| Usage metrics | Request volumes, error rates, resource utilization | Performance benchmarking |
Quome will not analyze:
- Application source code content (only metadata such as language, framework, and build method)
- Database row-level data (only schema structure and query patterns)
- Secret values (never accessed or logged)
- File contents in storage buckets (only metadata such as count, size, and type distributions)
- User-to-user communications
3. Expiration of R&D License
3.1 Automatic Expiration on Conversion
The R&D license granted in Section 2.1 automatically expires upon the earlier of:
(a) the date you convert to a paid Subscription plan;
(b) the date your free trial period ends (whether by expiration or cancellation); or
(c) the date you notify us in writing (including via email to legal@quome.com) that you wish to revoke the R&D license.
3.2 Effect of Expiration
Upon expiration of the R&D license:
(a) Quome will cease all R&D processing of your identifiable User Content within 30 days;
(b) Any de-identified or aggregated data derived from your User Content prior to expiration may be retained and used indefinitely, as it cannot reasonably be attributed to you;
(c) Your User Content will thereafter be subject only to the standard license terms in Section 4.2 of the Terms of Service; and
(d) No additional action is required from you — the transition is automatic upon conversion to a paid plan.
3.3 Paid Users
Users on paid Subscription plans are not subject to the R&D data usage rights described in Section 2.1. Paid users' data is used solely to provide, maintain, and improve the Services as described in the standard Terms of Service and Privacy Notice.
4. Transparency
4.1 Notice
Quome will clearly indicate in the Service interface when you are operating under a free trial and subject to these Trial Terms. The free trial status will be visible in your account settings and billing pages.
4.2 Inquiries
You may contact us at legal@quome.com at any time to:
(a) Request information about how your data has been used for R&D Purposes during your trial;
(b) Request early revocation of the R&D license (per Section 3.1(c)); or
(c) Request deletion of any R&D-derived data that can reasonably be attributed to you.
5. Relationship to Other Terms
These Trial Terms do not modify or supersede:
- The Business Associate Addendum — PHI is never subject to R&D usage
- The Privacy Notice — personal data processing remains governed by the Privacy Notice
- Any cloud provider's terms of service — your cloud provider agreement is between you and the provider
In the event of any conflict between these Trial Terms and the Business Associate Addendum, the Business Associate Addendum prevails.
Upgrading to a paid plan immediately terminates the R&D data usage license. We believe this creates a clear incentive aligned with our users' interests: free users contribute to platform improvement, and paid users receive the full benefit of those improvements with the strongest data protection terms.